We performed two 5-question surveys of oncologists in the US to gauge the impact of cancer treatment costs on prescribed therapies.
Published: 10th August 2015
Number of pages:15
We performed two five-question surveys of U.S. oncologists to gauge the impact of cancer treatment costs on prescribed therapies. In these surveys, we asked oncologists questions about cancer treatment costs from multiple angles:
Impact of drug pricing and value on cancer treatment plans
Financial impact of cancer treatment on patients
Frequency of conversations between physicians and cancer patients on drug/treatment pricing
Hypothetical prescribing levels of new cancer drugs with given price and efficacy parameters.
Table of contents
Question 1: How many patients with the following types of cancers are currently in your care?
Question 2: What percentage of your current patients have each of the following as a primary payer?
Question 3: How often does cancer drug out-of-pocket cost to patients affect your treatment recommendations?
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726